Revenue
$36.4B
▲ 8.4% YoY
Net Income
$4.8B
▲ 3.0% YoY
EPS
$3.73
▲ 3.3% YoY
Cash
$1.9B
▼ 12.1% YoY
FY 2026 · As of 2026-04-24
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Marinaro Michael EVP, Pres MedSurg and Americas | Sell tax | Aug 20, 2026 | 1.1K | $92.30 | $100K | Form 4 ↗ |
Blomquist Denise L. Chief Accounting Officer | Grant | Aug 3, 2026 | 2.3K | $0.00 | $0 | Form 4 ↗ |
Walter Matthew R. SVP, Chief HR Officer | Grant | Aug 3, 2026 | 5.8K | $0.00 | $0 | Form 4 ↗ |
Thompson Kweli EVP & President, Neuroscience | Grant | Aug 3, 2026 | 6.9K | $0.00 | $0 | Form 4 ↗ |
Quinn Michelle EVP, GC and Secretary | Grant | Aug 3, 2026 | 6.3K | $0.00 | $0 | Form 4 ↗ |
Pieton Thierry EVP & Chief Financial Officer | Grant | Aug 3, 2026 | 11.5K | $0.00 | $0 | Form 4 ↗ |
Marinaro Michael EVP, Pres MedSurg and Americas | Grant | Aug 3, 2026 | 11.0K | $0.00 | $0 | Form 4 ↗ |
Marinaro Michael EVP, Pres MedSurg and Americas | Grant | Aug 3, 2026 | 46.1K | $0.00 | $0 | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Grant | Aug 3, 2026 | 9.2K | $0.00 | $0 | Form 4 ↗ |
Martha Geoffrey Chairman and CEO | Grant | Aug 3, 2026 | 41.5K | $0.00 | $0 | Form 4 ↗ |
Blomquist Denise L. Chief Accounting Officer | Sell tax | Jul 31, 2026 | 212 | $85.39 | $18K | Form 4 ↗ |
Walter Matthew R. SVP, Chief HR Officer | Sell tax | Jul 31, 2026 | 1.7K | $85.39 | $143K | Form 4 ↗ |
Thompson Kweli EVP & President, Neuroscience | Sell tax | Jul 31, 2026 | 1.7K | $85.39 | $148K | Form 4 ↗ |
Marinaro Michael EVP, Pres MedSurg and Americas | Sell tax | Jul 31, 2026 | 3.4K | $85.39 | $287K | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell tax | Jul 31, 2026 | 3.1K | $85.39 | $262K | Form 4 ↗ |
Martha Geoffrey Chairman and CEO | Sell tax | Jul 31, 2026 | 15.8K | $85.39 | $1.35M | Form 4 ↗ |
Quinn Michelle EVP, GC and Secretary | Sell tax | Jul 28, 2026 | 2.1K | $86.88 | $180K | Form 4 ↗ |
Walter Matthew R. SVP, Chief HR Officer | Sell | Jul 8, 2026 | 3.1K | $83.15 | $258K | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Jun 8, 2026 | 4.0K | $80.44 | $319K | Form 4 ↗ |
KIIL HARRY SKIP EVP & President Cardiovascular | Sell | Jun 8, 2026 | 228 | $80.45 | $18K | Form 4 ↗ |